Revolution Medicines discovers and develops new medicines for cancer patients, with a focus on frontier targets in RAS-addicted cancers.

We combine deep chemical biology and cancer pharmacology know-how with sophisticated structure-based drug discovery capabilities and astute precision medicine approaches to develop novel targeted therapies.

Read more

We are developing novel targeted therapies to inhibit elusive frontier oncology targets within notorious growth and survival pathways, with a particular emphasis on the RAS and associated signaling pathways.

Read more

We are pursuing both combination and monotherapy precision medicine development strategies for our programs to allow us to target specific oncogenic mutations and combat adaptive resistance.

Read more
background

Publications and Presentations

The information included below was provided in connection with a presentation or publication on the date indicated and is qualified as such. Revolution Medicines disclaims any duty to update these materials.